Cargando…
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is known as the most difficult molecular subtype of breast cancer to treat. Recent studies revealed that cancer stem cells (CSCs) play a critical role in TNBC recurrence and metastasis. In this study, we developed a recombinant replication-deficient adenoviral ve...
Autores principales: | A, Ruhan, Kunimura, Naoto, Tominaga, Shoko, Hirata, Erika, Nishioka, Shunya, Uesugi, Misato, Yamazaki, Rion, Ueki, Hideto, Kitagawa, Koichi, Fujisawa, Masato, Shirakawa, Toshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090503/ https://www.ncbi.nlm.nih.gov/pubmed/37064130 http://dx.doi.org/10.3389/fonc.2023.1147668 |
Ejemplares similares
-
Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2018) -
Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2020) -
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting
por: Ruffo, Elisa, et al.
Publicado: (2023) -
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Moghimi, Babak, et al.
Publicado: (2021) -
Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
por: Kunimura, Naoto, et al.
Publicado: (2020)